Dr. Kevin F. Ginn
Claim this profileChildren's Mercy Hospitals and Clinics
Expert in Cancer
Expert in Neuroblastoma
36 reported clinical trials
58 drugs studied
About Kevin F. Ginn
Education:
- Obtained MD from the University of Kansas School of Medicine in 2015.
- Completed Residency in Pediatrics at Children's Mercy Hospitals and Clinics (2015-2018).
- Undertook Fellowship in Pediatric Cardiology at Children's Mercy Hospitals and Clinics (2018-2021).
Experience:
- Currently serving as a Pediatric Cardiologist at Children's Mercy Hospitals and Clinics.
Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Neuroblastoma
Global LeaderMYC positive
Stage IV
Stage I
Affiliated Hospitals
Clinical Trials Kevin F. Ginn is currently running
DFMO
for Medulloblastoma
Difluoromethylornithine (DFMO) will be used in an open label, multicenter, study as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma.
Recruiting1 award Phase 2
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
More about Kevin F. Ginn
Clinical Trial Related8 years of experience running clinical trials · Led 36 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Kevin F. Ginn has experience with
- Gemcitabine
- Cyclophosphamide
- Ramucirumab
- Temozolomide
- Nivolumab
- Brentuximab Vedotin
Breakdown of trials Kevin F. Ginn has run
Neuroblastoma
Soft Tissue Sarcoma
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kevin F. Ginn specialize in?
Kevin F. Ginn focuses on Cancer and Neuroblastoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage I.
Is Kevin F. Ginn currently recruiting for clinical trials?
Yes, Kevin F. Ginn is currently recruiting for 9 clinical trials in Kansas City Missouri. If you're interested in participating, you should apply.
Are there any treatments that Kevin F. Ginn has studied deeply?
Yes, Kevin F. Ginn has studied treatments such as Gemcitabine, Cyclophosphamide, Ramucirumab.
What is the best way to schedule an appointment with Kevin F. Ginn?
Apply for one of the trials that Kevin F. Ginn is conducting.
What is the office address of Kevin F. Ginn?
The office of Kevin F. Ginn is located at: Children's Mercy Hospitals and Clinics, Kansas City, Missouri 64108 United States. This is the address for their practice at the Children's Mercy Hospitals and Clinics.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.